These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17008028)

  • 1. The possible role of protein X, a putative auxiliary factor in pathological prion replication, in regulating a physiological endoproteolytic cleavage of cellular prion protein.
    Hachiya NS; Imagawa M; Kaneko K
    Med Hypotheses; 2007; 68(3):670-3. PubMed ID: 17008028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intriguing nucleic-acid-binding features of mammalian prion protein.
    Silva JL; Lima LM; Foguel D; Cordeiro Y
    Trends Biochem Sci; 2008 Mar; 33(3):132-40. PubMed ID: 18243708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of the pathogenic conformational change of the prion protein by an attractor of low order.
    Havsteen BH
    J Theor Biol; 2004 Nov; 231(1):39-48. PubMed ID: 15363928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
    Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
    J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glypican-1 facilitates prion conversion in lipid rafts.
    Hooper NM
    J Neurochem; 2011 Mar; 116(5):721-5. PubMed ID: 20681952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
    Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
    Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel sorting nexin SNX33 interferes with cellular PrP formation by modulation of PrP shedding.
    Heiseke A; Schöbel S; Lichtenthaler SF; Vorberg I; Groschup MH; Kretzschmar H; Schätzl HM; Nunziante M
    Traffic; 2008 Jul; 9(7):1116-29. PubMed ID: 18419754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octapeptide repeat region of prion protein (PrP) is required at an early stage for production of abnormal prion protein in PrP-deficient neuronal cell line.
    Sakudo A; Wu G; Onodera T; Ikuta K
    Biochem Biophys Res Commun; 2008 Jan; 365(1):164-9. PubMed ID: 17981146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient inhibition of prion replication by PrP-Fc(2) suggests that the prion is a PrP(Sc) oligomer.
    Masel J; Genoud N; Aguzzi A
    J Mol Biol; 2005 Feb; 345(5):1243-51. PubMed ID: 15644218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient in vitro amplification of a mouse-adapted scrapie prion protein.
    Murayama Y; Yoshioka M; Yokoyama T; Iwamaru Y; Imamura M; Masujin K; Yoshiba S; Mohri S
    Neurosci Lett; 2007 Feb; 413(3):270-3. PubMed ID: 17174030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prions and their biology].
    Gasset M; Westaway D
    Rev Neurol; 2000 Jul 16-31; 31(2):129-32. PubMed ID: 10951668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the natural variability of prion diseases.
    Geissen M; Krasemann S; Matschke J; Glatzel M
    Vaccine; 2007 Jul; 25(30):5631-6. PubMed ID: 17391814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seeded conversion of recombinant prion protein to a disulfide-bonded oligomer by a reduction-oxidation process.
    Lee S; Eisenberg D
    Nat Struct Biol; 2003 Sep; 10(9):725-30. PubMed ID: 12897768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling and analysis of prion dynamics in the presence of a chaperone.
    Kumar R; Murali P
    Math Biosci; 2008 May; 213(1):50-5. PubMed ID: 18362035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular prion protein co-localizes with nAChR beta4 subunit in brain and gastrointestinal tract.
    Petrakis S; Irinopoulou T; Panagiotidis CH; Engelstein R; Lindstrom J; Orr-Urtreger A; Gabizon R; Grigoriadis N; Sklaviadis T
    Eur J Neurosci; 2008 Feb; 27(3):612-20. PubMed ID: 18279314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
    Sasaki K; Minaki H; Iwaki T
    J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PrP N-terminal domain triggers PrP(Sc)-like aggregation of Dpl.
    Erlich P; Cesbron JY; Lemaire-Vieille C; Curt A; Andrieu JP; Schoehn G; Jamin M; Gagnon J
    Biochem Biophys Res Commun; 2008 Jan; 365(3):478-83. PubMed ID: 17997980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PrPSc-like prion protein peptide inhibits the function of cellular prion protein.
    Brown DR
    Biochem J; 2000 Dec; 352 Pt 2(Pt 2):511-8. PubMed ID: 11085945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion and anti-codon usage: does infectious PrP alter tRNA abundance to induce misfolding of PrP?
    Rechavi O; Kloog Y
    Med Hypotheses; 2009 Feb; 72(2):193-5. PubMed ID: 18809261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prion processing: a double-edged sword?
    McMahon HE
    Biochem Soc Trans; 2012 Aug; 40(4):735-8. PubMed ID: 22817725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.